diaphorase
Patent Information
- Application Number
- JP2023084531
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-12-05
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
【0009】 本発明によれば、充分なジアホラーゼ活性を有し、臨床診断·産業利用における使用に、より適したジアホラーゼを提供することができる。
Abstract
Description
[Technical field]
[0001] The present invention relates to a novel diaphorase. [Background technology]
[0002] Diaphorase (EC.1.6.5.2) has been investigated for in vitro use in various technical fields, and some applications have been put to practical use.
[0003] For example, in the technical field of clinical diagnosis, diaphorase is used in various in vitro diagnostic reagents, taking advantage of its property of using reduced nicotinamide adenine dinucleotide (NADH) as a substrate.
[0004] An example of an in vitro diagnostic reagent is an ammonia measurement reagent using the enzyme cycling method. + from NAD in the presence of adenosine 5'-triphosphate + Synthetic enzymes catalyze NAD + is produced, and then NADH is produced by glucose and glucose dehydrogenase. At this time, NADH is oxidized in the presence of tetrazolium salt and diaphorase, and is converted back to NAD + From there, glucose and glucose dehydrogenase further produce NADH, a so-called cycling reaction. In this example, ammonia can be quantitatively measured by measuring the absorbance of formazan, which is the reaction product (see Patent Document 1). [Prior art documents] [Patent documents]
[0005] [Patent Document 1] Patent No. 4127767 Summary of the Invention [Problem to be solved by the invention]
[0006] An object of the present invention is to provide a diaphorase which has sufficient diaphorase activity and is more suitable for use in clinical diagnosis and industrial applications. [Means for solving the problem]
[0007] As a result of intensive efforts to solve the above problems, the present inventors have found that the problems can be solved by using diaphorase produced by the DI-1 strain (NITE P-03816), and have completed the present invention.
[0008] In order to achieve the above object, the present invention provides the following diaphorase. [1] Diaphorase produced by the DI-1 strain (NITE P-03816). Effect of the Invention
[0009] According to the present invention, it is possible to provide a diaphorase that has sufficient diaphorase activity and is more suitable for use in clinical diagnosis and industrial applications. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, an embodiment of the present invention (hereinafter, referred to as "the present embodiment") will be described in detail. Note that the present invention is not limited to the following embodiment, and can be modified in various ways within the scope of the present invention.
[0011] The diaphorase according to this embodiment is an enzyme produced by the DI-1 strain (NITE P-03816).
[0012] To distinguish this strain from known ones, it was named strain DI-1 and deposited at the Patent Microorganisms Depositary Center of the National Institute of Technology and Evaluation as strain DI-1 (NITE P-03816).
[0013] In producing the diaphorase according to the present embodiment, a microorganism is cultured in a nutrient medium to produce diaphorase in the cells or in the culture solution. After the culture is completed, if the product is in the cells, the cells are collected from the culture by means of filtration or centrifugation, and then the cells are destroyed mechanically or enzymatically using lysozyme to obtain a cell extract. If the product is released outside the cells and in the culture solution, the cells and insoluble components in the culture solution may be removed by centrifugation or filtration. If necessary, EDTA, PMSF, a protease inhibitor, and / or a suitable surfactant may be added to concentrate the aqueous solution of diaphorase, or the aqueous solution may be treated with ammonium sulfate fractionation, gel filtration, adsorption chromatography such as affinity chromatography, or ion exchange chromatography without concentration to obtain diaphorase with high purity. When determining the sequence of the produced diaphorase, known methods such as the Edman degradation method and mass spectrometry may be used.
[0014] The culture conditions for the microorganisms may be selected taking into consideration their nutritional and physiological properties, and in most cases, liquid culture is used, but from an industrial perspective, submerged aeration and stirring culture is advantageous. As nutrient sources for the medium, a wide range of nutrients commonly used for microbial culture can be used.
[0015] The carbon source may be any assimilable carbon compound, such as glucose, saccharose, lactose, maltose, fructose, glycerol, molasses, etc. The nitrogen source may be any usable nitrogen compound, such as peptone, meat extract, yeast extract, soybean protein, casein hydrolysate, etc.
[0016] The amount (concentration) of each component during culture can be appropriately selected within the range in which diaphorase is produced, following the method described in a non-patent document (Journal of Industrial Microbiology & Biotechnology (1999) 23, 456-475).
[0017] In addition, salts of phosphates, carbonates, sulfates, magnesium, calcium, potassium, iron, manganese, zinc, copper, etc., specific amino acids, specific vitamins, etc. may be used as needed.
[0018] The culture temperature can be appropriately changed within a range in which the microorganism grows and produces diaphorase.
[0019] The diaphorase in the culture can be collected and used as it is in the culture solution containing the cells, but generally, when diaphorase is present in the culture solution, it is used after separating the diaphorase-containing solution from the microbial cells by filtration, centrifugation, or the like according to a conventional method. When filtration is difficult, the use of a filter aid such as perlite is considered for removing the cells and insoluble components, and when centrifugation is difficult, the use of a flocculant such as a soluble polymer having an ion exchange group is considered, and it is a conventional method to add an appropriate economical step. When diaphorase is present in the cells, the cells are collected from the obtained culture by means of filtration or centrifugation, and then the cells are destroyed by mechanical methods or enzymatic methods such as lysozyme and zymolyase, and, if necessary, a chelating agent such as EDTA, a protease inhibitor such as PMSF, and / or a surfactant is added to solubilize the diaphorase and separate and collect it as an aqueous solution.
[0020] The diaphorase-containing solution thus obtained may be precipitated by a fractional precipitation method such as vacuum concentration, membrane concentration, and further salting out with ammonium sulfate, sodium sulfate, or the like.
[0021] The precipitate can then be dissolved in water and dialyzed with a semipermeable membrane to remove lower molecular weight impurities. Alternatively, the precipitate can be purified by gel filtration using an adsorbent or gel filtration agent, adsorption chromatography such as affinity chromatography, ion exchange chromatography, etc., and purified diaphorase can be obtained from the diaphorase-containing solution obtained by these means by treatments such as vacuum concentration and freeze-drying.
[0022] It was confirmed that the diaphorase according to the present embodiment has sufficient diaphorase activity and is practical. Therefore, the diaphorase according to the present embodiment is useful industrially, particularly as an enzyme for in vitro diagnosis.
[0023] The present invention will now be described with reference to examples, but the present invention is not limited to these examples. EXAMPLES
[0024] <Diaphorase (DI) activity measurement method> [Reaction Reagent Mixture] 0.2M KH2PO4-NaOH buffer (pH8.0) 0.5ml 0.25%(W / V) NTB solution 0.1ml 1%(W / V) BSA solution 0.1ml 10mM NADH solution 0.1ml Purified water 0.2ml [Enzyme dissolving dilution solution] 0.1M KH2PO4-NaOH buffer (pH 8.0) containing 0.1% (W / V) BSA [Reaction stop solution] 0.1N HCl solution
[0025] Dispense 1.0 ml of the above reaction reagent mixture into a small test tube and preheat at 37°C for 5 minutes. Then, add 0.1 ml of the enzyme sample solution diluted B times with the above enzyme dissolving dilution solution, mix, and start the enzyme reaction at 37°C. After 10 minutes, add 2.0 ml of the above reaction stop solution, mix, and stop the reaction. Measure the absorbance at 550 nm (As). As a blank test, perform the same procedure using the above enzyme dissolving dilution solution instead of the enzyme sample solution and measure the absorbance (Ab) (As-Ab). The absorbance difference (As-Ab) between the absorbance using this enzyme sample solution (As) and the absorbance of the blank test (Ab) is defined as ΔA, and calculate the enzyme activity using the following formula. The enzyme dilution ratio B is set so that ΔA≦0.370. One unit of enzyme activity (1 unit) is the amount of 1 μmol of NADH converted to NAD per minute at 37°C. + The amount of enzyme converted to
[0026] Enzyme activity (U / mL)={(ΔA / 10) / 12.4}×(3.10 / 0.10)×B 10: Reaction time (min) 12.4: Millimolar extinction coefficient (cm) of NTBH2 at 550 nm 2 / μmol) 3.10: Total reaction volume (ml) 0.10: Amount of enzyme sample solution used in the reaction (ml)
[0027] <Production and activity measurement of diaphorase (DI)> The DI-1 strain (NITE P-03816) was precultured in LB medium, the preculture solution was suspended in a medium containing glycerol, yeast extract, peptone, etc., and cultured at 34°C for 24 hours using a 2L culture device. The culture solution after the culture was centrifuged to collect the cells. The cells were then mechanically disrupted to solubilize the diaphorase, and the activity of the centrifuged supernatant was measured using the DI activity measurement method described above, and the enzyme activity was calculated to be 95.0 U / mL.
Claims
[Claim 1] Diaphorase produced by strain DI-1 (NITE P-03816).
Citation Information
Patent Citations
Liquid-storable enzyme cycling-based measurement reagents
JP4127767B2
